Latest News and Press Releases
Want to stay updated on the latest news?
-
ROCKVILLE, Md., Oct. 01, 2021 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announces the appointment of Dr. Marcus A. Conant, a leading dermatologist in the U.S. and one of the first...
-
ROCKVILLE, Md., July 15, 2021 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today that the Data and Safety Monitoring Board (DSMB) voted unanimously to continue AGT’s HIV cure...
-
ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today that the first trial participant was enrolled in the Phase 1 trial of AGT103-T, a new cell and gene...
-
ROCKVILLE, Md., Oct. 08, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) a cutting-edge cell and gene therapy company in Rockville, Maryland announced today that CEO Jeff Galvin will...
-
ROCKVILLE, Md., Aug. 11, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today approval by the FDA (Food and Drug Administration) to begin Phase 1, the first human clinical trial...
-
ROCKVILLE, Md., July 30, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), an internationally recognized advanced gene and cell therapy company in Rockville, MD, today announced a...
-
ROCKVILLE, Md., July 28, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), an internationally recognized leading gene and cell therapy company in Rockville, Maryland, today announced it has...
-
ROCKVILLE, Md., March 10, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a leading gene and cell therapy company in Rockville, Maryland, is pleased to announce its Chief Science Officer C....
-
ROCKVILLE, Md., Jan. 08, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Executive Officer, Jeff Galvin, will attend the 38th annual J.P. Morgan Healthcare...
-
ROCKVILLE, Md., Nov. 06, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today it will host a red carpet event tonight to celebrate a significant milestone in the company’s...